Novel Interaction Mechanism of a Domain Antibody-based Inhibitor of Human Vascular Endothelial Growth Factor with Greater Potency than Ranibizumab and Bevacizumab and Improved Capacity over Aflibercept (Q36674580)
Jump to navigation
Jump to search
scientific article published on 4 January 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Novel Interaction Mechanism of a Domain Antibody-based Inhibitor of Human Vascular Endothelial Growth Factor with Greater Potency than Ranibizumab and Bevacizumab and Improved Capacity over Aflibercept |
scientific article published on 4 January 2016 |
Statements
1 reference
Novel Interaction Mechanism of a Domain Antibody-based Inhibitor of Human Vascular Endothelial Growth Factor with Greater Potency than Ranibizumab and Bevacizumab and Improved Capacity over Aflibercept (English)
1 reference
Adam Walker
1 reference
Chun-Wa Chung
1 reference
Margarete Neu
1 reference
Manish Burman
1 reference
Thil Batuwangala
1 reference
Gavin Jones
1 reference
Chi-Man Tang
1 reference
Michael Steward
1 reference
Michael Mullin
1 reference
Nadia Tournier
1 reference
Alan Lewis
1 reference
Justyna Korczynska
1 reference
Vicky Chung
1 reference
Ian Catchpole
1 reference
4 January 2016
1 reference
1 reference
5500-5511
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference